Nucleus RadioPharma
United States
- Rochester, MN
- 18/10/2023
- Series A
- $56,000,000
Transforming lives with radiopharmaceuticals by leveraging world class clinical, development, manufacturing, and supply chain expertise. Nucleus bridges the gap between innovation and clinic.
- Industry Pharmaceutical Manufacturing
- Website https://nucleusrad.com/
- LinkedIn https://www.linkedin.com/company/nucleus-radiopharma/about/
Related People
Charles ConroyFounder
United States -
Charlotte Metro
Contact: csconroyrph@gmail.com
Skilled negotiator and decision maker with excellent leadership, problem solving and relationship building skills. Expertise includes:
• Specialty Pharmacy
• Pharmacy Operations Management
• Business Development
• Product Development and Launch
• Alliance Management
• Strategic Planning
• Market Planning
• Corporate and Product Strategy
• Team Leadership and Development
• Acquisition Integration
• Operational Improvement
Specialties: Strategic Development, Pharmaceutical Marketing, Medical Device Marketing, Contract Negotiation, Nuclear Medicine, Process Management, New Business Start-up, Acquisitions, Mergers, Divestitures, Six Sigma, Sterile Compounding, Pharmaceutical Compounding, 340B, Supply Chain, Supply Chain Management
SetSale | $2,000,000 | (Mar 19, 2026)
Raven.io | $20,000,000 | (Mar 19, 2026)
Manifold Security | $8,000,000 | (Mar 19, 2026)
Beautiful.ai | $45,000,000 | (Mar 19, 2026)
xmemory | $4,000,000 | (Mar 19, 2026)
Laminar (YC S24) | $3,000,000 | (Mar 19, 2026)
Obin AI | $7,000,000 | (Mar 19, 2026)
Multiply(US) | $9,500,000 | (Mar 19, 2026)
Respan (formerly Keywords AI) | $5,000,000 | (Mar 19, 2026)
Homaio | $4,135,744 | (Mar 19, 2026)
Foresight(UK) | $25,000,000 | (Mar 19, 2026)
VerbaFlo.AI | $7,000,000 | (Mar 18, 2026)